News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Europe Ahead In IPOs


10/19/2005 5:09:25 PM

July 5, 2005 -- Europe led the US in IPOs in the second quarter. Only two biotech IPOs were completed on US exchanges, versus five in the European markets. In the US, Xenoport Inc.was the bigger offering, raising $52.5 million through the sale of 5 million shares at $10.50. Gentium S.p.A., an Italian company, was the only other one. Gentium raised $21.6 million through the sale of 2.4 million shares at $9 on the AMEX. All in all, only $74.1 million was raised in US public markets, a decidedly weak performance. In contrast, the five companies going public on European exchanges raised nearly $255 million. We look at the IPO market and its implications for biotech funding...

Read at ChinaBio Today

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES